首頁 > 市場調查報告書 > 製藥

疼痛

市場調查報告書

商品編碼

1566218

合法大麻市場規模、佔有率、成長分析、按來源、按衍生物、按最終用途、按地區 - 產業預測，2024-2031 年

Legal Cannabis Market Size, Share, Growth Analysis, By Source (Marijuana, Hemp), By Derivative (CBD, THC), By End-use (Medical Use, Industrial Use), By Region - Industry Forecast 2024-2031

出版日期: 2024年10月06日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年全球合法大麻市場規模為222億美元，從2023年的279.1億美元成長到2031年的1,739.3億美元，預測期間(2024-2031年)複合年成長率預計將成長25.70%。

在各地區日益接受和合法化努力的推動下，全球合法大麻市場正經歷顯著成長。該市場具有雙重目的：滿足對藥用大麻產品不斷成長的需求，以治療慢性疼痛、癲癇和化療引起的噁心等健康問題。認知到大麻的治療功效，許多國家將醫用大麻合法化，有助於擴大市場。然而，該行業面臨挑戰。特別是，缺乏標準化法規導致品管和安全不一致，為消費者和企業帶來不確定性。更多領域的合法化不僅擴大了潛在的消費群體，也拓展了商業前景。此外，栽培技術、遺傳學和萃取方法的創新可以提高產品質量，同時提高效率並降低成本。在法規不斷變化和消費者偏好不斷變化的背景下，合法大麻市場為尋求滿足醫療和娛樂產品不斷成長的需求的公司提供了一條有吸引力的成長道路。儘管面臨監管複雜性和安全問題等挑戰，但整體市場軌跡表明，透過有效使用大麻，有機會為經濟成長和公共衛生做出貢獻。

市場概況
醫療用途
- 癌症
- 慢性疼痛
- 憂鬱症和焦慮
- 關節炎
- 糖尿病
- 青光眼
- 偏頭痛
- 癲癇
- 多發性硬化症
- 愛滋病
- 肌萎縮側索硬化症
- 阿茲海默症
- 創傷後壓力症候群（PTSD）
- 帕金森氏症
- 妥瑞症
- 其他
娛樂用途
工業用途

合法大麻市場規模：按地區分類

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Canopy Growth Corporation（Canada）
Aurora Cannabis, Inc.（Canada）
Cronos Group（Canada）
Sundial Growers Inc.（Canada）
The Scotts Company LLC（US）
VIVO Cannabis Inc.（Canada）
Cara Therapeutics Inc.（US）
Curaleaf Holdings, Inc.（US）
Trulieve Cannabis Corp.（US）
Green Thumb Industries Inc.（US）
Cresco Labs Inc.（US）
MedMen Enterprises Inc.（US）
Acreage Holdings, Inc.（US）
TerrAscend Corp.（Canada）
Organigram Holdings Inc.（Canada）
Liberty Health Sciences Inc.（US）
iAnthus Capital Holdings, Inc.（US）
Planet 13 Holdings Inc.（US）
High Tide Inc.（Canada）
Jushi Holdings Inc.（US）
4Front Ventures Corp.（US）

簡介目錄

Product Code: SQMIG35J2105

Global Legal Cannabis Market size was valued at USD 22.2 billion in 2022 and is poised to grow from USD 27.91 billion in 2023 to USD 173.93 billion by 2031, growing at a CAGR of 25.70% during the forecast period (2024-2031).

The global legal cannabis market is experiencing remarkable growth, fueled by the rising acceptance and legalization efforts in various regions. This market serves dual purposes, fulfilling the escalating demand for medicinal cannabis products intended for treating health issues like chronic pain, epilepsy, and chemotherapy-induced nausea. The recognition of cannabis's therapeutic benefits has prompted many countries to embrace medical cannabis legalization, propelling market expansion. However, the industry faces challenges, notably a lack of standardized regulations leading to inconsistent quality control and safety concerns, which create uncertainty for both consumers and businesses. Nevertheless, the landscape is ripe with opportunities; increasing legalization across more jurisdictions not only broadens the potential consumer base but also enhances business prospects. Additionally, innovations in cultivation techniques, genetics, and extraction methods can elevate product quality while improving efficiency and reducing costs. With a backdrop of changing regulations and evolving consumer preferences, the legal cannabis market presents attractive growth avenues for companies aiming to meet the burgeoning demand for both medicinal and recreational products. Despite challenges such as regulatory complexities and safety apprehensions, the market's overall trajectory suggests substantial opportunities for economic growth and contributions to public health through effective cannabis usage.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Legal Cannabis market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Legal Cannabis Market Segmental Analysis

Global Legal Cannabis Market is segmented by Source, Derivative, End-use, and region. Based on Source, the market is segmented into Marijuana, and Hemp. Based on Derivative, the market is segmented into CBD, THC, Others. Based on End-use, the market is segmented into Medical Use, Recreational Use, and Industrial Use. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Global Legal Cannabis Market

The growing acceptance of cannabis for both medical and recreational purposes is a significant market driver for the Global Legal Cannabis market. As countries increasingly recognize the therapeutic benefits of cannabis, along with its potential to generate substantial tax revenues and create jobs, governments are actively shifting towards legalization. This progressive legal landscape fosters investment opportunities, encourages research and development, and enhances consumer access to cannabis products. The embrace of cannabis not only promotes public health through regulated use but also stimulates economic growth, positioning legal cannabis as a pivotal sector in the evolving global marketplace.

Restraints in the Global Legal Cannabis Market

The global legal cannabis market is significantly restrained by the complex and inconsistent regulatory landscape that varies across countries and regions. These disparate legal frameworks complicate compliance for businesses, leading to increased operational costs and legal uncertainties. Companies often struggle to navigate this patchwork of regulations, which impacts their ability to scale operations, secure investments, and innovate within the market. Furthermore, the lack of uniform standards can deter potential investors wary of the legal ramifications, thereby stifling growth opportunities. This regulatory inconsistency not only hinders market expansion but also limits consumer access and trust in legal cannabis products.

Market Trends of the Global Legal Cannabis Market

The Global Legal Cannabis market has experienced a significant trend towards product diversification, particularly since 2022, as companies strive to appeal to a wider range of consumers. Beyond the traditional flower and concentrates, the market is increasingly budding with innovative offerings, including edibles, beverages, and topicals, enhancing consumer engagement and driving demand. This strategic expansion not only attracts new demographics, including health-conscious individuals and casual users, but also fosters brand loyalty as companies experiment with unique formulations and experiences. As a result, the cannabis sector is evolving, positioning itself as a versatile industry capable of meeting diverse consumer preferences in an expanding marketplace.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

Legal Cannabis Market by Source

Market Overview
Marijuana
- Flowers
- Oil and Tinctures
Hemp
- Hemp CBD
- Supplements
- Industrial Hemp

Legal Cannabis Market by Derivative

Market Overview
CBD
THC
Others

Legal Cannabis Market by End-use

Market Overview
Medical Use
- Cancer
- Chronic Pain
- Depression and Anxiety
- Arthritis
- Diabetes
- Glaucoma
- Migraines
- Epilepsy
- Multiple Sclerosis
- AIDS
- Amyotrophic Lateral Sclerosis
- Alzheimer's
- Post-Traumatic Stress Disorder (PTSD)
- Parkinson's
- Tourette's
- Others
Recreational Use
Industrial Use

Legal Cannabis Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Canopy Growth Corporation (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aurora Cannabis, Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cronos Group (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sundial Growers Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
The Scotts Company LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
VIVO Cannabis Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cara Therapeutics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Curaleaf Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Trulieve Cannabis Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Green Thumb Industries Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cresco Labs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MedMen Enterprises Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acreage Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
TerrAscend Corp. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Organigram Holdings Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Liberty Health Sciences Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
iAnthus Capital Holdings, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Planet 13 Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
High Tide Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Jushi Holdings Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
4Front Ventures Corp. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments